You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti CD19 CAR-T cells

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Cancer Trial (experimental:Acute leukemia/myelodysplastic or myeloproliferative disease)

Not yet recruiting
  • Hematologic Cancer
  • experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
  • (no location specified)
Oct 26, 2022

Myeloid Leukemia, Chronic Trial in France (Glivec)

Terminated
Has Results
  • Myeloid Leukemia, Chronic
  • Bordeaux, France
  • +6 more
Nov 5, 2021

Recurrent Ovarian High Grade Serous Adenocarcinoma, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in United States

Suspended
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
  • Phoenix, Arizona
  • +8 more
Jul 26, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Obstructive Sleep Apnea Trial in Boston (Placebo oral capsule, Atomoxetine Oral Capsule [Strattera])

Recruiting
  • Obstructive Sleep Apnea
  • Placebo oral capsule
  • Atomoxetine Oral Capsule [Strattera]
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 25, 2022

Healthy Adults (45-65 Years) Trial in Hangzhou (Bifidobacterium adolescentis, Placebo)

Not yet recruiting
  • Healthy Adults (45-65 Years)
  • Bifidobacterium adolescentis
  • Placebo
  • Hangzhou, Zhejiang, China
    Sir RUN RUN Shaw Hospital, School of Medicine, Zhejiang Universi
Oct 28, 2022

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Orthodontic Appliance Complication, Dental Malocclusion, Bone Anchored Rapid Maxillary Expansion Trial in Salamanca (Rapid

Completed
  • Orthodontic Appliance Complication
  • +4 more
  • Rapid Maxillary Expansion
  • Salamanca, Spain
  • +2 more
Apr 25, 2023

Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

Completed
  • Cutaneous T-cell Lymphoma (CTCL)
  • +4 more
  • Duarte, California
  • +18 more
Nov 19, 2020

Dysphagia, Cervical Spine Disease Trial in Montreal (Dexamethasone, Placebo)

Withdrawn
  • Dysphagia
  • Cervical Spine Disease
  • Montreal, Quebec, Canada
    Centre Hospitalier de l'Université de Montréal (CHUM)
Dec 12, 2022

Nasopharyngeal Carcinoma Trial in Guangzhou (Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel),

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Apatinib, Camrelizumab, Chemotherapy (gemcitabine/ capecitabine/ docetaxel)
  • +3 more
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Sep 17, 2022

Autophagy/Apoptosis Balance During Pregnancy

Recruiting
  • Pregnancy Related
  • Blood test
  • Nîmes, France
    CHU de Nimes
Sep 20, 2022

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Overweight and Obesity, Stunted Growth, Malnutrition, Child Trial in Mérida (Experimental intervention group with enriched

Completed
  • Overweight and Obesity
  • +3 more
  • Experimental intervention group with enriched cookies
  • Mérida, Yucatán, Mexico
    Facultad de Química, Unidad Académica de la UNAM en Yucatán
May 31, 2021

Asherman Syndrome, Atrophic Endometrium, Recurrent Implantation Failure Trial in Orange (Plerixafor)

Not yet recruiting
  • Asherman Syndrome
  • +2 more
  • Orange, Connecticut
    Yale Fertility Center
Jul 13, 2022

Severe Congenital Neutropenia, GATA2 Deficiency Trial in Moscow (conditioning with TLI)

Not yet recruiting
  • Severe Congenital Neutropenia
  • GATA2 Deficiency
  • conditioning with TLI
  • Moscow, Russian Federation
    HSCT department
Apr 9, 2021

Frontotemporal Dementia Trial (ET-STEM)

Not yet recruiting
  • Frontotemporal Dementia
  • (no location specified)
May 11, 2022

HIV, Pregnancy Trial in Puerto Rico, United States (Lamivudine, Stavudine, Zidovudine)

Completed
  • HIV Infections
  • Pregnancy
  • Los Angeles, California
  • +19 more
Oct 27, 2021

NSCLC Trial (PM8002, Placebo, Carboplatin)

Not yet recruiting
  • NSCLC
  • (no location specified)
Feb 23, 2023

Allogeneic Hematopoietic Cell Transplantation Trial in Cleveland (Nicotinamide riboside (NR))

Recruiting
  • Allogeneic Hematopoietic Cell Transplantation
  • Nicotinamide riboside (NR)
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023

Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)

Completed
Has Results
  • Prostate Cancer
  • 70.2 Gy 3D-CRT/IMRT
  • 79.2 Gy 3D-CRT/IMRT
  • Long Beach, California
  • +85 more
Dec 27, 2022

Colorectal Carcinoma Trial in United States (MGD007)

Completed
  • Colorectal Carcinoma
  • New Haven, Connecticut
  • +7 more
Feb 4, 2022

Different Anti-Müllerian Hormone Isoforms in Expected Poor

Completed
  • Anti-Mullerian Hormone Isoforms
    • Abu Dhabi, United Arab Emirates
      IVI Middle East Fertility Clinic
    Aug 4, 2022

    Colorectal Cancer Trial in Zagreb (Lidocaine, Ketamine, Lidocaine and Ketamine)

    Completed
    • Colorectal Cancer
    • Lidocaine
    • +3 more
    • Zagreb, Croatia
      The Anti-inflammatory Effect of Anesthetics in Abdominal Surgery
    May 14, 2022

    Breast Cancer Trial in Worldwide (Trastuzumab Emtansine)

    Completed
    Has Results
    • Breast Cancer
    • Trastuzumab Emtansine
    • Buenos Aires, Argentina
    • +299 more
    Mar 31, 2022